Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

PLoS One · 2013 · PMC3543433 · PMID 23326319

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not achieve significancep = 0.05actually significant

Cytotoxicity was also trended greater against TMZ-resistant U373 with γδ TMZ-R as effectors as well when the assay was conducted in the presence of TMZ (p = .0875) but did not achieve significance at the p = 0.05 level.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.